Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.148 (
Thy1
)
1,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have previously identified the
engulfment and cell motility 1
(
ELMO1
) as a susceptibility gene for diabetic nephropathy. To elucidate the role of
ELMO1
in the pathogenesis of chronic renal injury, we examined the expression of Elmo1 in the kidney of a rat model for chronic glomerulonephritis (uninephrectomy plus anti-
Thy1
.1 antibody [E30] injection). We found that the expression of the Elmo1 was significantly increased in the renal cortex and glomeruli of uninephrectomized rats injected with E30 compared to controls. By in situ hybridization, the expression of Elmo1 was shown to be elevated in the diseased kidney, especially in glomerular epithelial cells. In COS cells, the overexpression of
ELMO1
resulted in a substantial increase in fibronectin expression, whereas the depletion of the
ELMO1
by small interfering RNA (siRNA) targeting
ELMO1
significantly suppressed the fibronectin expression in
ELMO1
overexpressing and control cells. We also found that the expression of integrin-linked kinase (ILK) was significantly increased in
ELMO1
overexpressing cells, and the
ELMO1
-induced increase in fibronectin was partially, but significantly, inhibited by siRNA targeting ILK. Furthermore, we identified that the cell adhesion to ECMs was considerably inhibited in cells overexpressing
ELMO1
. These results suggest that the
ELMO1
contributes to the development and progression of chronic glomerular injury through the dysregulation of ECM metabolism and the reduction in cell adhesive properties to ECMs.
...
PMID:ELMO1 increases expression of extracellular matrix proteins and inhibits cell adhesion to ECMs. 1702